Australia markets open in 7 hours 48 minutes

Sutro Biopharma, Inc. (STRO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.9000-0.6000 (-13.36%)
As of 12:12PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 368.84M
Enterprise value -30.63M
Trailing P/E 85.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.76
Price/book (mrq)2.42
Enterprise value/revenue 0.36
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 319.36%
S&P500 52-week change 326.33%
52-week high 36.1300
52-week low 32.0100
50-day moving average 34.0376
200-day moving average 34.0574

Share statistics

Avg vol (3-month) 3763.11k
Avg vol (10-day) 3558.61k
Shares outstanding 581.96M
Implied shares outstanding 681.96M
Float 864.56M
% held by insiders 10.93%
% held by institutions 178.13%
Shares short (30 Aug 2024) 43.02M
Short ratio (30 Aug 2024) 44.78
Short % of float (30 Aug 2024) 43.72%
Short % of shares outstanding (30 Aug 2024) 43.68%
Shares short (prior month 31 July 2024) 43.19M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -73.48%
Operating margin (ttm)-189.39%

Management effectiveness

Return on assets (ttm)-13.91%
Return on equity (ttm)-81.10%

Income statement

Revenue (ttm)169.36M
Revenue per share (ttm)2.56
Quarterly revenue growth (yoy)146.90%
Gross profit (ttm)N/A
EBITDA -99.12M
Net income avi to common (ttm)-124.45M
Diluted EPS (ttm)-1.7800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)425.99M
Total cash per share (mrq)5.2
Total debt (mrq)26.53M
Total debt/equity (mrq)17.43%
Current ratio (mrq)3.41
Book value per share (mrq)1.86

Cash flow statement

Operating cash flow (ttm)-74.72M
Levered free cash flow (ttm)20.67M